ArticleBiotechnology letters2026
Metabolic engineering of tobacco plants using Carica papaya NAC transcription factors: a biotechnology tool to improve plant metabolite production.
Article in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Plant secondary metabolism includes the biosynthesis of a wide array of molecules with significant biological and biotechnological applications. However, the regulatory mechanisms governing secondary metabolite production remain largely elusive. Key master regulators of gene expression, such as transcription factors (TFs), are expected to play a central role in controlling the biosynthesis of these compounds. In this context, the present study addresses a critical knowledge gap by elucidating the regulatory role of Carica papaya NAC transcription factors (CpNACs) in reprogramming secondary metabolites in Nicotiana tabacum. Thus, this work advances our understanding of plant metabolic engineering by identifying molecular links between transcription factor regulation and metabolite accumulation. Methanolic extracts from transformed and non-transformed plants were analyzed by gas chromatography-mass spectrometry (GC-MS). The results showed altered accumulation of some specialized metabolites. Specifically, targeted metabolomics revealed increased accumulation of phytosterols, including campesterol, β-sitosterol, and stigmasterol. Non-targeted metabolomics further indicated extensive metabolic reprogramming, affecting pools of organic acids, steroids, and lipids. Furthermore, transformed seedlings showed elevated levels of phenylpropanoids (e.g., coumarin, sinapaldehyde), alkaloids (e.g., tropinone, allocryptopine), and derivatives of aromatic amino acids (e.g., tryptamine, phenylacetic acid). The increased abundance of key metabolic intermediates, such as acetate and acetyl-CoA, suggests a redirection of metabolic flux toward the biosynthesis of these specialized compounds. Our findings suggest that CpNAC transcription factors may regulate specialized metabolite biosynthetic pathways, potentially by modulating metabolic flux at specific enzymatic steps within these networks. This pioneering study proposes an alternative that could improve the performance and productivity of biotechnological processes for obtaining valuable compounds from plants, highlighting the potential of transcription factor-based approaches to manipulate complex plant metabolic networks.
Indexed as
Identifiers
42507024What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.